Transcend plans for acquiring DTS by the merger of DTS and a subsidiary of Transcend.
The acquisition is expected to be of $7.9m in cash, plus an earn-out of up to $4.2m payable in cash (if earned) in 2012.
The closing is subject to certain pre-closing conditions, including completion of due diligence and negotiation and execution of a definitive purchase agreement.
Transcend CEO Larry Gerdes said they are excited to have the opportunity to serve DTS’s customers and look forward to being able to offer them a greater array of flexible solutions to meet their clinical documentation needs.